Mevalonate pathway
(Redirected from Cholesterol synthesis)
Mevalonate pathway is a crucial metabolic pathway present in eukaryotes, archaea, and some bacteria. This pathway is vital for the biosynthesis of isoprenoids or terpenoids, including cholesterol, steroid hormones, and vitamin K. The mevalonate pathway involves a series of enzymatic reactions that convert acetyl-CoA to isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP), which are the building blocks for the synthesis of more complex isoprenoids.
Overview[edit | edit source]
The mevalonate pathway begins in the cytosol, where acetyl-CoA is converted into 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). This reaction is catalyzed by the enzyme HMG-CoA synthase. Subsequently, HMG-CoA is reduced to mevalonate by HMG-CoA reductase, a key regulatory enzyme and the target of statins, drugs used to lower cholesterol levels. Mevalonate is then phosphorylated and decarboxylated to yield isopentenyl pyrophosphate (IPP), which can be isomerized to dimethylallyl pyrophosphate (DMAPP). These two five-carbon molecules serve as the precursors for the synthesis of all other isoprenoids.
Key Enzymes[edit | edit source]
- HMG-CoA Synthase: Catalyzes the synthesis of HMG-CoA from acetyl-CoA.
- HMG-CoA Reductase: Reduces HMG-CoA to mevalonate, a rate-limiting step in the pathway.
- Mevalonate Kinase: Phosphorylates mevalonate to mevalonate-5-phosphate.
- Phosphomevalonate Kinase: Converts mevalonate-5-phosphate to mevalonate-5-diphosphate.
- Mevalonate-5-diphosphate Decarboxylase: Decarboxylates mevalonate-5-diphosphate to IPP.
Biological Significance[edit | edit source]
The mevalonate pathway is essential for the synthesis of numerous biomolecules that play critical roles in various biological processes. For example, cholesterol is a vital component of cell membranes and a precursor for the synthesis of steroid hormones, bile acids, and vitamin D. Isoprenoids produced via this pathway are also involved in protein prenylation, a post-translational modification that affects protein localization and function.
Regulation[edit | edit source]
The mevalonate pathway is tightly regulated, primarily at the step catalyzed by HMG-CoA reductase. This enzyme is subject to both transcriptional and post-translational regulation. Statins, which are inhibitors of HMG-CoA reductase, effectively reduce cholesterol synthesis, demonstrating the importance of this regulatory point.
Clinical Significance[edit | edit source]
Disruptions in the mevalonate pathway can lead to various metabolic disorders. For instance, mutations in the gene encoding mevalonate kinase can cause mevalonate kinase deficiency, which is characterized by recurrent fever episodes and inflammatory symptoms. Furthermore, the pathway's role in cholesterol biosynthesis makes it a target for therapeutic intervention in cardiovascular diseases.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD